Skip to main content
$35.94 -$0.06 (-0.2%)

04:00 PM EST on 12/08/23

Gsk Plc (NYSE:GSK)

CAPS Rating: 2 out of 5

The Company is a global healthcare group which is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter medicines and health-related consumer products.

Current Price $35.94 Mkt Cap $73.2B
Open $35.92 P/E Ratio 9.76
Prev. Close $35.94 Div. (Yield) $1.39 (3.7%)
Daily Range $35.84 - $36.09 Volume 1,507,605
52-Wk Range $33.20 - $38.32 Avg. Daily Vol. 3,523,790

Caps

How do you think NYSE:GSK will perform against the market?

Add Stock to CAPS Watchlist

All Players

1,380 Outperform
82 Underperform
 

All-Star Players

266 Outperform
20 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:GSK Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

brittlee43 (< 20)
Submitted February 07, 2020

Good dividends, strong company

CMFTomato (53.40)
Submitted August 08, 2018

Facing the threat of generic Advair, but also a lot of debt on the balance sheet, forcing GSK to put a lot of their profits toward interest payments. Yet their dividend is one of the highest among their industry peers. This is great for shareholders… More

Recent Community Commentary

Read the most recent pitches from players about GSK.

Recs

0
Member Avatar TMFjimhalley (< 20) Submitted: 3/21/2022 4:59:36 PM : Outperform Start Price: $41.01 NYSE:GSK Score: -15.45

The company expects to increase margins after its spinoff from its consumer healthcare division. It also has a strong portfolio in oncology and an above-average dividend for a pharmaceutical company.

Recs

1
Member Avatar brittlee43 (< 20) Submitted: 2/6/2020 9:19:54 PM : Outperform Start Price: $36.56 NYSE:GSK Score: -39.80

Good dividends, strong company

Recs

1
Member Avatar CMFTomato (53.40) Submitted: 8/7/2018 8:46:54 PM : Underperform Start Price: $32.43 NYSE:GSK Score: +50.26

Facing the threat of generic Advair, but also a lot of debt on the balance sheet, forcing GSK to put a lot of their profits toward interest payments. Yet their dividend is one of the highest among their industry peers. This is great for shareholders hanging on for the dividend but not such great news for the long-term growth of the stock. Therefore, underperform.

Leaderboard

Find the members with the highest scoring picks in GSK.

Score Leader

niwhsa

niwhsa (78.91) Score: +362.90

The Score Leader is the player with the highest score across all their picks in GSK.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
niwhsa 78.91 11/20/2008 Underperform 3Y $15.88 +126.70% +489.60% +362.90 0 Comment
stockpickeraz < 20 1/16/2009 Underperform 5Y $17.08 +110.76% +454.92% +344.16 0 Comment
stoneyg72 86.14 4/1/2009 Underperform 3W $14.67 +145.38% +477.45% +332.07 0 Comment
lwc123 92.43 1/8/2009 Underperform 3Y $18.34 +96.25% +419.44% +323.19 0 Comment
TRGoodvsEvil 97.52 7/6/2009 Underperform 5Y $16.59 +116.91% +419.92% +303.01 0 Comment
longterm007 82.64 10/31/2008 Underperform 5Y $18.06 +99.30% +396.06% +296.75 0 Comment
MIKEP75731 50.25 5/22/2009 Underperform 5Y $15.91 +126.21% +422.42% +296.21 1 Comment
janiceelaine < 20 10/6/2008 Underperform 3Y $19.72 +82.55% +340.64% +258.10 0 Comment
PurePwnage 96.05 11/27/2009 Underperform 5Y $20.44 +76.08% +324.54% +248.46 0 Comment
allmymarbles 52.31 2/19/2010 Underperform 5Y $19.04 +89.00% +316.02% +227.01 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for GSK.